FDA
approval
· 2023-03-28
FDA Approved: VUITY — Supplemental Application (AbbVie Inc.)
Summary
FDA approved a supplemental application for VUITY (pilocarpine hydrochloride) submitted by AbbVie.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VUITY (PILOCARPINE HYDROCHLORIDE)